Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Current Funding Prohibits CDRH From Achieving User Fee Goals – McClellan

This article was originally published in The Gray Sheet

Executive Summary

At least three members of the House Appropriations Committee are closely monitoring the status of device user fee funding in the FY 2004 budget

You may also be interested in...



Effective Public Education Campaign Espoused By FDA Deputy Commissioner

The far-reaching consequences of an underfunded FDA for the device industry should be communicated to the general public, Deputy Commissioner Lester Crawford advised AdvaMed members at their annual meeting March 21 in Aventura, Fla

Effective Public Education Campaign Espoused By FDA Deputy Commissioner

The far-reaching consequences of an underfunded FDA for the device industry should be communicated to the general public, Deputy Commissioner Lester Crawford advised AdvaMed members at their annual meeting March 21 in Aventura, Fla

User Fee Funds Will Not Be Confined To Premarket Review Activities – Feigal

Device user fees will be allocated toward activities other than premarket review as CDRH struggles to compensate for fiscal 2003 appropriation shortfalls

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017999

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel